Respect intros line of breakfast sandwiches
Respect Foods last week debuted a new line of frozen breakfast products for immediate distribution in North America.
Drug Store Product News
Walkers Shortbread rolls out gluten-free varieties
Walkers Shortbread has adapted its shortbread recipe for consumers who abide by a gluten-free diet.
Ankle Roll Guard launches product to prevent ankle sprains
Ankle Roll Guard on Friday announced the launch of the Armor1 Ankle Roll Guard, a new patented support that prevents ankle sprains by cushioning the ankle from an inversion or "roll."
Alberto VO5 introduces dual-purpose beauty oil
Alberto VO5 has introduced its first-ever dual purpose, after-shower product for hair and body: Shine, Glow & Go Beauty Oil.
Camber launches generic Protonix
Camber Pharmaceuticals on Thursday announced the launch of pantoprazole sodium delayed-release tablets USP, the generic version of Pfizer's Protonix. The drug is used to treat gastro esophageal reflux disease and damage to the esophagus.
Lipton's new line aims to uplift
Lipton Iced Tea is rolling out a new line of lightly carbonated ice teas, which highlights the brand's "Be More Tea" brand philosophy of encouraging people to refresh their daily routines.
Chobani hopes to 'excite the shelf' with latest products
Greek yogurt brand Chobani is adding several products to its portfolio along with new marketing initiatives to maintain category leadership, the company announced on Wednesday.
Glucose Health launches powder blend to promote healthy glucose levels
Glucose Health recently launched a powder blend that can assist in the stabilization of healthy glucose levels, the company announced.
Red Carpet Manicure teams up with Walt Disney for Cinderella Collection
Nail care company Red Carpet Manicure has announced the launch of the limited edition Cinderella Collection in partnership with Walt Disney for the release of the live-action version of “Cinderella” hitting theaters on March 13.
FDA approves Consentyx from Novartis
The Food and Drug Administration on Wednesday announced approval for Cosentyx (secukinumab), indicated for the treatment of adults with moderate to severe plaque psoriasis.